COVID19: Three Indian Vaccines In Different Phases Of Clinical Testing Says ICMR
Mumbai: The Indian Council of Medical Research (ICMR) reported on Tuesday that there are three Indian COVID-19 vaccines in the country which are in various stages of clinical trials.
Dr. Balaram Bhargava, DG, ICMR while addressing a press conference here said,” Currently, we have three Indian vaccines which are in various stages of clinical trials. 2 vaccines – Bharat Biotech Vaccine and Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine.”
“The Oxford vaccine, which is being manufactured by the Serum Institute of India (SII), has been approved for Phase 2 and 3 clinical trials, starting at 17 sites within a week,” he said.
However, Dr. Bhargava said that social disturbances and proper sanitation are the best “vaccines” available right now and beyond.
https://twitter.com/ANI/status/1290613675443724289?s=19
“Body distance, wearing a mask, proper hand hygiene is the best vaccines available at this time and even beyond. We have to continue these measures,” he said.
A one-day spike of 52,050 COVID-19 cases was observed in India as the total number of cases in the country reached 18,55,746 on Tuesday.
The number of cured/discharged/migrated patients stands at 12,30,510 and 38,938 persons have died, the Health Ministry added.
Follow us on Twitter, Instagram, and like us on Facebook for the latest updates and interesting stories.
